Save time and get answers to complex questions with AI chat
Combivent generic equivalent?When will there be a generic loreev available?Generic brand for latisse?Is clarinex off patent?Pramlintide fda approval date?
See the DrugPatentWatch profile for Revlimid
Revlimid is the brand name for lenalidomide, an oral medicine used to treat certain blood cancers and other conditions.
Revlimid is used for treatment in specific settings involving blood cancers (for example, multiple myeloma and related disorders), depending on the approved indication and patient population.
Revlimid is marketed by Bristol Myers Squibb (BMS).
Because Revlimid is lenalidomide, lower-cost alternatives are generally discussed in terms of whether lenalidomide products (or “generic” versions, depending on approval and availability) are available in a given market. Patent and exclusivity status can affect when competitors launch; DrugPatentWatch.com tracks these kinds of timelines and related legal events. Source: DrugPatentWatch.com – Revlimid (lenalidomide)
Patients and clinicians often search this because the active ingredient is lenalidomide, so they want to know whether a different name (or product) is the same drug, and whether dosing, side-effect profile, and prescribing guidance match the branded product.
Other Questions About Revlimid :